Company AB Science Deutsche Boerse AG

A8D

FR0010557264

Pharmaceuticals

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

EPS Revisions

Annual profits - Rate of surprise

Sector Specialty & Advanced Pharmaceuticals

Market Closed - Deutsche Boerse AG Other stock markets 02:04:49 2024-06-28 EDT			5-day change	1st Jan Change
1.1 ^EUR	-2.31%		-6.94%	-69.70%

06-28	AB Science: negative CHMP opinion for masitinib in ALS	CF
06-03	AB Science: share price falls on resumption of trading	CF

AB Science specializes in research, development, and sales of kinase protein inhibitors (KPI), therapeutic drugs used in treating cancerous tumors, inflammatory and neuro-degenerative diseases in both humans and animals.

Number of employees: 54

EUR in Million	2022	Weight	2023	Weight	Delta
Protein Kinase Inhibitors 100.0 %	1	100.0 %	1	100.0 %	+1.25%

EUR in Million	2022	Weight	2023	Weight	Delta
France 100.0 %	1	100.0 %	1	100.0 %	+1.25%

Managers	Title	Age	Since
Alain Moussy CEO	Chief Executive Officer	-	01-07-10
Laurent Guy DFI	Director of Finance/CFO	-	01-12-31
Christian Fassotte CTO	Chief Tech/Sci/R&D Officer	-	18-03-31
Alexis Bernard PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
Alain Moussy CEO	Chief Executive Officer	-	01-07-10
Patrick Moussy BRD	Director/Board Member	-	01-07-10
Cécile de Guillebon BRD	Director/Board Member	62	21-06-26
Catherine Johnston-Roussillon BRD	Director/Board Member	66	21-06-26
Guillemette Latscha BRD	Director/Board Member	-	21-06-26
Renaud Sassi BRD	Director/Board Member	-	21-06-26

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	51,111,703	32,744,501 ( 64.06 %)	0	64.06 %

Name	Equities	%	Valuation
Alain Moussy 37.12 %	19,331,068	37.12 %	41 M €
Financière Arbevel SA 0.1618 %	84,283	0.1618 %	178 420 €
La Française Asset Management SAS 0.1498 %	78,000	0.1498 %	165 120 €
Chameleon Asset Management AG 0.008641 %	4,500	0.008641 %	9 526 €
Ursus-3 Capital, AV, SA 0.005953 %	3,100	0.005953 %	6 562 €
Irish Life Investment Managers Ltd. 0.004006 %	2,086	0.004006 %	4 416 €
Amundi Asset Management SA (Investment Management) 0.001970 %	1,026	0.001970 %	2 172 €
Mercer Global Investments Europe Ltd. 0.001216 %	633	0.001216 %	1 340 €

AB Science SA

3, avenue George V

75008, Paris

+33 1 47 20 00 14

http://www.ab-science.com

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.116 EUR

Average target price

6.895 EUR

Spread / Average Target

+517.83%

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Specialty & Advanced Pharmaceuticals

	1st Jan change	Capi.
MERCK KGAA	+7.39%	72.09B
KYOWA KIRIN CO. LTD.	+15.93%	9.05B
YUHAN CORPORATION	+17.59%	4.39B
SK BIOPHARMACEUTICALS CO., LTD.	-22.81%	4.4B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+25.93%	3.94B
INDIVIOR PLC	+4.64%	2.1B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+9.09%	1.97B
BETTA PHARMACEUTICALS CO., LTD.	-36.86%	1.87B
VELOXIS PHARMACEUTICALS A/S	-0.50%	1.64B

Specialty & Advanced Pharmaceuticals